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Abstract 24 
Background  Inflamed environments are typically hypercellular, rich in pro-inflammatory 25 
cytokines, and profoundly hypoxic.  While the effects of hypoxia on neutrophil longevity 26 
and function have been widely studied, little is known about the consequences of this 27 
stimulus on eosinophils.   28 
Objective  We sought to investigate the effects of hypoxia on several key aspects of 29 
eosinophil biology; namely secretion, survival, and their sensitivity to 30 
glucocorticosteroids (GCS), agents which normally induce eosinophil apoptosis.   31 
Methods  Eosinophils derived from patients with asthma/atopy or healthy controls were 32 
incubated under normoxia and hypoxia, with or without  glucocorticoids.  Activation was 33 
measured by flow cytometry, ELISA of cultured supernatants and F-actin staining; 34 
apoptosis and efferocytosis by morphology and flow cytometry, and GCS efficacy by 35 
apoptosis assays and qPCR.   36 
Results  Hypoxic incubation (3 kPa) caused: (i) stabilisation of HIF-2α and up-regulation 37 
of hypoxia regulated genes including BNIP3 (BCL2/adenovirus E1B 19 kDa protein-38 
interacting protein 3) and GLUT1 (glucose transporter 1), (ii) secretion of pre-formed IL-39 
8, and Charcot Leyden crystal (CLC) formation, that was most evident in eosinophils 40 
derived from atopic and asthmatic donors, (iii) enhanced F-actin formation, (iv) marked 41 
prolongation of eosinophil lifespan (via a NF-κB and Class I PI3-kinase-dependent 42 
mechanism), and (v) complete abrogation of the normal pro-apoptotic effect of 43 
dexamethasone and fluticasone furoate.  This latter effect was evident despite 44 
preservation of GCS-mediated gene transactivation under hypoxia.   45 
Page | 3 Porter et al. 
 
Conclusion and Clinical Relevance  These data indicate that hypoxia promotes an 46 
eosinophil pro-inflammatory phenotype by enhancing eosinophil secretory function, 47 
delaying constitutive apoptosis and importantly, antagonising the normal pro-apoptotic 48 
effect of GCS.  Since eosinophils typically accumulate at sites that are relatively hypoxic, 49 
particularly during periods of inflammation, these findings may have important 50 
implications to understanding the behaviour these cells in vivo. 51 
 52 
Introduction 53 
Eosinophils are innate immune cells involved in allergic inflammation.  While recent 54 
studies have highlighted certain beneficial effects of eosinophils (e.g. to support muscle 55 
regeneration [1], maintain bone marrow plasma cell numbers [2], regulate the biogenesis 56 
of beige fat [3] and promote respiratory syncytial virus clearance  [4]), most indicate a 57 
pathogenic role for these cells in inflammation [5].  The damaging potential of 58 
eosinophils has been attributed to their ability to generate and secrete an array of highly 59 
histotoxic products, most of which are contained within pre-stored granules; this is 60 
achieved either by exocytosis, cytolysis or piecemeal degranulation [6].  These processes 61 
permit the selective release of a highly active ‘secretome’ consisting of cationic proteins, 62 
pro-inflammatory cytokines, bio-active lipids and reactive oxygen intermediates.  In 63 
addition, Charcot Leyden crystals (CLCs) are eosinophil-derived bipyramidal structures 64 
found in tissues and body fluids of patients suffering from eosinophilic inflammation, 65 
typically affecting the airways [7].  While the dominant CLC protein (galectin-10) has 66 
now been recognised as a member of the lectin family [8], the processes leading to CLC 67 
formation remain poorly understood.  Moreover, the CLC protein appears to be highly 68 
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pro-inflammatory; for example, galectin-10 mRNA is overexpressed in aspirin-induced 69 
asthma and CLCs have been shown to damage respiratory epithelium and increase 70 
vascular permeability [9]. 71 
 72 
Allergic inflammation is thought to delay the capacity of eosinophils to undergo 73 
constitutive apoptosis [10], and in animal models, accelerating eosinophil apoptosis 74 
promotes the resolution of allergic inflammation [11].  Corticosteroids, working through 75 
the glucocorticoid receptor (GR), are highly efficient in suppressing allergic 76 
inflammation, in part through their capacity to suppress degranulation and secretory 77 
responses and potentially also through their ability to drive eosinophil apoptosis [12][13].  78 
However, despite the exquisite sensitivity of eosinophils to the pro-apoptotic effects of 79 
GR agonists in vitro, a significant subset of patients with eosinophilic inflammation 80 
exhibit glucocorticoid-resistant disease; such individuals present a major therapeutic 81 
conundrum and utilise disproproportionate health care resources [14].  Of note, much of 82 
the experimental work undertaken to define the biology of eosinophils has been 83 
conducted under ambient oxygen concentrations, typically 21 kPa.  This relatively 84 
‘hyperoxic’ state may have little relevance to the physiological PO2 these cells encounter 85 
in vivo, with both sterile and non-sterile inflammation able to reduce the level of tissue 86 
oxygenation still further, often to PO2 values below 1 kPa; this predicates the need for 87 
myeloid cells to operate efficiently under hypoxic conditions [15][16][17]. 88 
We have shown that neutrophils express the oxygen sensing prolyl hydroxylase enzymes 89 
PHD1-3 and the transcriptional factors HIF-1α and HIF-2α, and although well adapted to 90 
survive under hypoxia, are extremely sensitive to the ambient PO2 [15].  Hence, a drop in 91 
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oxygen levels to 3 KPa (which equates to physiological oxygen tensions in the skin [18], 92 
gut [19], and bone marrow [20]) causes a marked inhibition of neutrophil NADPH oxidase-93 
dependent ROS generation and bacterial killing [21].  Hypoxia also impairs spontaneous 94 
neutrophil apoptosis, the latter through a HIF-1α- and NF-κB-dependent pathway [15].   95 
 96 
In contrast, eosinophil responses under hypoxia have been far less studied.  HIF-1α and 97 
HIF-2α are both expressed in murine eosinophils and appear to regulate eosinophil 98 
chemotaxis [22] and in vitro, hypoxia has been reported to up-regulate the inhibitory 99 
receptor CD300a, enhance eosinophil viability, and cause a small increase in basal IL-8 and 100 
VEGF release [23][24].  However, the effects of hypoxia on the pro-apoptotic and anti-101 
inflammatory effects of corticosteroids on eosinophils are unknown.  This question has 102 
important biological relevance, not only because of the hypoxic environment commonly 103 
encountered by eosinophils in vivo, but because of reports in other cell types that hypoxia 104 
can induce a state of glucocorticoid resistance [25]. 105 
 106 
Using ultra-pure human blood eosinophils, we now show that hypoxia is a potent 107 
stimulus of spontaneous and agonist-stimulated IL-8 release, an effect which is most 108 
evident in cells purified from atopic and asthmatic donors.  We also report for the first 109 
time that culture of human eosinophils results in overt CLC formation only when cells are 110 
purified from atopic donors and, perhaps more critically, when these cultures are 111 
performed under hypoxic conditions (PO2 3 kPa).  In addition, we demonstrate that 112 
hypoxia antagonises the normal pro-apoptotic effect of dexamethasone and as a 113 
consequence reduces the extent of efferocytosis by monocyte-derived macrophages.  114 
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Mechanistically, the capacity of hypoxia to inhibit eosinophil apoptosis appears to relate 115 
to the ability of this stimulus to ‘out-compete’ the normal pro-apoptotic effect of 116 
corticosteroids, as GR-mediated nuclear signalling is preserved under hypoxia [26].  117 
These studies illustrate the significant effects of physiologically and pathologically 118 
relevant levels of hypoxia on eosinophil function, and the capacity of hypoxia to 119 
attenuate one of the major anti-inflammatory effects of corticosteroids. 120 
  121 
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Methods 122 
These studies were approved by the Cambridge Research Ethics Committee, UK 123 
(06/Q0108/281); written informed consent was obtained from all participants.   124 
 125 
Isolation of human peripheral blood neutrophils and eosinophils 126 
Human peripheral blood neutrophils were purified from healthy donors using dextran 127 
sedimentation and discontinuous plasma-Percoll gradients as detailed [27].  Human 128 
eosinophils were isolated from healthy volunteers, mildly atopic donors (with appropriate 129 
history and a positive skin prick test to one or more aeroallergens) and individuals with 130 
asthma (physician-diagnosed on Step 1 or 2 BTS Guideline treatment), using HetaSep™ 131 
hetastarch sedimentation and Robosep® and EasySep® Human Eosinophil Enrichment 132 
Kits (Stem Cell Technologies, Manchester, UK), according to manufacturers’ instructions.  133 
Cell purities (assessed by cytospin preparations stained with Diff-Quick™) were >95% for 134 
neutrophils and >99% for eosinophils (Fig. 1A).  Both of these isolation methods have been 135 
demonstrated by our group to induce minimal cell priming/activation as judged in 136 
neutrophils by lack of basal shape change or oxidative burst to fMLP [28] and in 137 
eosinophils by unperturbed cell surface expression of CD69, CD44, CD81 and CD66b, 138 
shape change, EM-assessed granule morphology, and eosinophil-derived neurotoxin (EDN) 139 
release [29]. 140 
 141 
Hypoxic culture of eosinophils and neutrophils 142 
Purified eosinophils were re-suspended at 1-2 x 106 cells/ml in RPMI supplemented with 143 
10% (v/v) autologous serum, 100 U/ml streptomycin and 100 U/ml penicillin.  Neutrophils 144 
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were re-suspended at 5 x 106 cells/ml in Iscove’s modified Dulbecco’s medium (IMDM) 145 
supplemented with 10% (v/v) autologous serum, 100 U/ml streptomycin and 100 U/ml 146 
penicillin or Dulbecco’s phosphate buffered saline (PBS) containing CaCl2 and MgCl2 147 
(PBS+).  Apoptosis assays were undertaken in a final volume of 150 µl in flat-bottomed 96-148 
well (ultra-low attachment) Costar™ plates. 149 
 150 
Normoxic incubations utilised media equilibrated in a humidified 5% CO2 /air incubator 151 
(representing 19-21 kPa oxygen) whereas a hypoxic environment (typically an atmospheric 152 
oxygen concentration of 0.8%, giving a media PO2 of 2.8 ± 0.1 KPa, (n) = 20, with PCO2 153 
and pH values matched to the values under normoxic conditions) was achieved by culturing 154 
in a Ruskinn Invivo 400 hypoxic incubator.  All media were allowed to equilibrate for 3 hr 155 
prior to use and hypoxia confirmed using an ABL5 blood gas analyser (Radiometer, 156 
Denmark).  CO2 settings were titrated to ensure maintainence of a physiological pH and 157 
varied according to the buffering system.  The induction of hypoxia at a cellular level was 158 
confirmed by showing stabilisation of eosinophil HIF-2α using anti-HIF-2α (Novus 159 
Biologics, UK) (Fig. 1B).  Despite repeated attempts, HIF-1α could not be reliably detected 160 
by Western blot in human eosinophils. 161 
 162 
Western blot analysis 163 
Following culture of 1-5 million eosinophils/well in ultra-low attachment 6-well plates for 164 
6 hr under normoxia and hypoxia, the supernatants were removed and cells were lysed with 165 
100 µl of radio-immunoprecipitation assay (RIPA) buffer containing protease and 166 
phosphatase inhibitors (150 mM sodium chloride, 1% Triton X-100, 0.5% sodium 167 
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deoxycholate, 0.1% SDS (sodium dodecyl sulphate) and 50 mM Tris, pH 8.0 containing 168 
cOmpleteTM, EDTA-free Protease Inhibitor Cocktail Tablets, Roche).  The plates were 169 
snap-frozen using dry ice in industrial methylated spirit (IMS) and stored at -80°C until 170 
required, then later scraped and the lysates sonicated and analysed for protein content.  171 
Freshly isolated cells were re-suspended in the appropriate supplemented medium at 1-5 172 
million eosinophils/tube and pelleted at 256 g for 5 min at 4°C.  Pellets were also re-173 
suspended in 100 µl of RIPA buffer before being snap-frozen.  Samples were prepared by 174 
mixing with LDS sample buffer (4X) and heated to 70°C (for HIF1/2α detection on Tris-175 
acetate gels) for 10 min and allowed to cool to RT prior to loading and subsequent SDS-176 
PAGE analysis using Tris-acetate 3-15% gels.  Membranes were probed for HIF 177 
stabilisation using anti-HIF-1α anti-HIF-2α antibodies (Novus Biologics, UK) using the 178 
enhanced chemiluminescence (ECL) kit (Amersham Pharmacia Biotech) and normalised 179 
against p38 protein, as previously described [30].  180 
 181 
Assessment of apoptosis 182 
Eosinophil and neutrophil apoptosis was assessed using cell morphology and Annexin-183 
V/PI flow cytometry as described [31].  Since acidic microenvironments have been 184 
shown to enhance the viability of eosinophils, the tissue culture media contained 25 mM 185 
Hepes and the pH was monitored throughout the experiment [32].  Inhibitors and 186 
compounds used to investigate the effects of hypoxia on eosinophil lifespan and function 187 
included: NF-κB inhibitor GSK657311A, Class 1A PI3-kinase inhibitor 987740A, 188 
CXCR2 antagonist SB-3322357 and the GR modulator GRT10 (all gifted from Dr Stuart 189 
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Farrow, GSK); a pan-PI3K inhibitor LY294002 (Calbiochem, Nottingham, UK) and JNK 190 
inhibitor SP600125 (Sigma, UK).   191 
 192 
Assessment of eosinophil activation 193 
(i) Quantification of CLC formation 194 
CLC formation was assessed by examining Diff-Kwik™ stained cytospins; each 195 
treatment was scored for the number of CLCs formed across 5 random fields of view (AU 196 
Arbitary Units; 1 ≤ 25 CLCs [per 5 high power fields (hpfs)]; 2 = 25-50 CLCs [per 5 197 
hpfs]; 3 = 50+ CLCs [per 5 hpfs]). 198 
(ii) Actin polymerisation 199 
Eosinophils were re-suspended at 1x106/ml in PBS without cations (PBS-) and incubated 200 
in normoxic and hypoxic PBS- and left for 1 hr prior to stimulation.  Cells were then 201 
stimulated with fMLP (100 nM), eotaxin (100 nM) or vehicle for the time-points 202 
indicated and fixed in 4% formaldehyde.  After 1 hr, 100 µl NBD-buffer (NBD-203 
phallicidin in 1.5 ml of absolute methanol, 37% formaldehyde, PBS-, 0.2 mg/ml 204 
lysophosphtidylcholine) was added and the cells incubated in the dark for a further hour.  205 
Cells were analysed on a Fortessa (BD) flow cytometer using excitation with the 488 nm 206 
laser and emission measured at 525 nm (green fluorescence/FL1) [33].  207 
(iii) Analysis of CD69 cell surface expression 208 
Freshly isolated eosinophils were suspended in supplemented RPMI at 2 x 106 cells/ml 209 
and incubated in either a normoxic or hypoxic environment.  Cells were washed in FACS 210 
buffer (PBS-, 2 mM EDTA, 0.5% BSA and 0.1% sodium azide) and  re-suspended in 100 211 
µl FACS buffer containing 2.5 µl CD69-FITC conjugated antibody or IgG isotype control 212 
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(2.5 µl FITC-mouse IgG1κ).  The samples were incubated on ice for 30 min in the dark, 213 
washed and re-suspended in 500 µl FACS buffer prior to analysis.  214 
 215 
Macrophage phagocytosis assays 216 
Phagocytosis was measured by both light microscopy and flow cytometry.  Human 217 
monocytes isolated over discontinuous plasma-Percoll gradients were cultured in 24-well 218 
tissue culture plates for 7 days in RPMI with 100 ng/ml M-CSF to yield monocyte-derived 219 
macrophages (MDMφ).  For light microscopy assessment, 2 x 105 MDMφ in RPMI were 220 
incubated with 6 x 105 ‘bait’ cells (human neutrophils or eosinophils aged for 20-24 hours 221 
in vitro) for 1 hour (37°C,  5% CO2) in a normoxic (21%) or hypoxic environment (0.8%), 222 
and then fixed with 2.5% glutaraldehyde.  The cells were stained for myeloperoxidase 223 
(MPO) with 0.1 mg/ml dimethoxybenzidine and 0.03% (v/v) hydrogen peroxide in PBS 224 
(MDMφ are MPO-negative) [34].  The percentage of macrophages that had ingested one or 225 
more apoptotic granulocyte was quantified by examining a minimum of 300 cells in 226 
duplicate wells.  To confirm that the apoptotic neutrophils or eosinophils had been 227 
internalised, trypsinised cells were cytospun, stained with Diff-Kwik™, and examined 228 
under oil immersion. 229 
 230 
For flow cytometric quantification of phagocytosis, MDMφ (2 x 105/ml/200 µl/well) were 231 
prepared as above.  Normoxic or hypoxic eosinophils (1 x 107/ml in RPMI without serum) 232 
were stained with CMFDA cell tracker dye (1 µl/107 cells) for 15 min at 37°C.  The 233 
labelled cells were washed in RPMI and re-suspended at 3 x 106/ml in serum-free RPMI.  234 
MDMφ (6 x 105/well) were washed and co-incubated with 200 µl of CellTracker Green 235 
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CMFDA-labelled apoptotic eosinophils.  Following co-incubation for 1 hr at 37°C under a 236 
normoxic environment or hypoxic environment, media was replaced with 0.5 ml trypsin-237 
EDTA for 15 min at 37°C and 15 min at 4°C.  Vigorous pipetting was performed to ensure 238 
detachment of all adherent cells and the extent of MDMφ phagocytosis assessed by flow 239 
cytometry.  MDMφ were identified and gated according to their forward and side scatter 240 
characteristics;  MDMφ that had ingested apoptotic eosinophils showed an increase in 241 
green fluorescence, becoming FL-1 positive [34]. 242 
 243 
Cytokine and growth factor ELISAs and quantification of EDN release 244 
Eosinophils (106/ml) were incubated under normoxic or hypoxic conditions for 12 hr and 245 
supernatants collected, pooled (2,000 g, 6 min) and stored at -80°C.  Cytokines including 246 
IL-5, IL-6, IL-8, IL-10 and GM-CSF release were measured by ELISA using 96-well 247 
Microlon® plates according to the manufacturer’s instructions (Qiagen, Crawley, UK).  248 
Biotinylated secondary polyclonal antibody was measured using streptavidin conjugated 249 
alkaline phosphatase, the plates developed with p-nitrophenylphosphate and read at λ405 250 
nm using a Bio-Rad 550 micro-plate reader.  Additional confirmation of cytokine release 251 
from eosinophils was undertaken using Qiagen Multi-Analyte ELISArray plates used in 252 
accordance to manufacturers’ guidelines.  EDN release was measured by ELISA, according 253 
to  manufacturer’s guidelines (Immundiagnostik-AG, Bensheim, Germany; lower limit of 254 
detection 0.164 ng/ml).  Data were analysed using Microsoft Plate Manager (MPM) 1.57 255 
software.  256 
 257 
Neutrophil chemotaxis assays 258 
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Supernatants from normoxic or hypoxic eosinophils (or IL-8, 100 ng/ml) were placed 259 
underneath a NeuroProbe ChemoTx® disposable 96-well filter; freshly isolated 260 
neutrophils (5 x 106 cells/ml in IMDM plus 0.1% autologous serum) were added on top 261 
of the filter and incubated for 90 min at 37°C in a humidified normoxic incubator.  The 262 
suspension from each bottom well was collected and the wells washed twice with warm 263 
EDTA/trypsin.  Cell migration was assessed by haemocytometer cell counting. 264 
 265 
Measurement of dexamethasone- and hypoxia-regulated gene expression 266 
For RNA isolation, granulocytes were cultured in 6-well plates at 2 x 107 per well 267 
(neutrophils) or 1-5 x 106 per well (eosinophils), harvested, and the cell pellets re-268 
suspended in 1 ml TRIZOL® (Invitrogen); following chloroform extraction and 269 
isopropanol precipitation the RNA pellet was washed x2 with 1 ml ice-cold 70% (v/v) 270 
ethanol, air dried, re-suspended in 100 µl of nuclease free water (Promega), and a RNA 271 
clean-up and DNase digest performed using RNeasy micro-column kit (Qiagen).  A high 272 
capacity cDNA kit (Applied Biosystems) was used to generate cDNA using 1 µg of total 273 
RNA using the following program settings: 25°C for 10 min, 37°C for 2 hr, 85°C for 5 274 
min and 4°C on hold; RNA preparations were stored at -80°C. 275 
 276 
Changes in gene expression were assessed by qPCR using SYBR® Green Jumpstart™ 277 
Taq Readymix™ (Sigma), Rox reference dye (Invitrogen) and primers obtained from 278 
Qiagen (Suppl. Table 1).  The reactions were performed on a StepOnePlus™ (Applied 279 
Biosystems) real-time PCR machine or a 384-well 7900HT fast real time PCR machine 280 
(Applied Biosystems).  Primer efficiency was optimised to obtain the following PCR 281 
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settings: 2 min at 95°C for Taq polymerase activation, 40 cycles of denaturation for 30 282 
sec at 95°C, annealing for 30 sec at 55°C and extension for 30 sec at 72°C.  Cycle 283 
thoureshold (Ct) values from control and experimental sample sets were normalised to 284 
appropriate housekeeping genes (beta-2-microglobulin/YMHAZ/18s) (ΔΔCt = ΔCt, 285 
sample – ΔCt) and the relative change in target gene expression (fold change) analysed 286 
using the 2-ΔΔCT method [35].  287 
 288 
Data Analysis 289 
The results are reported as the mean ± SD or SE of (n) independent donor experiments 290 
with each treatment performed in triplicate for neutrophils and duplicate for eosinophils 291 
unless otherwise stated.  Data were analysed using the GraphPad Prism statistical analysis 292 
package.  Paired t-tests were used to compare the means from two groups when samples 293 
were obtained from the same donor and were of Gaussian distribution.  For the 294 
comparison of three or more groups, one-way ANOVA with a post-Tukey’s or Dunnett’s 295 
test was performed or two-way ANOVA was used when more than one variable was 296 
assessed, with a post-Tukey’s or Dunnett’s test for multiple comparisons.  A value of P 297 
<0.05 was considered significant.   298 
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Results 299 
Hypoxia stimulates basal and agonist-mediated IL-8 release from human eosinophils 300 
To determine whether hypoxia influences the release of inflammatory cytokines, human 301 
eosinophils were isolated and the supernatants collected following 12 hr of normoxia or 302 
hypoxia culture.  From the panel of chemokines and cytokines examined, enhanced IL-8 303 
levels and MIP-1β were observed in all subjects following hypoxic culture (Fig. 1C and 304 
Fig. S1).  Furthermore, the extent of IL-8 release correlated with the clinical diagnosis, with 305 
eosinophils from individuals with atopy and asthma having the highest levels of IL-8 306 
secretion under hypoxia (Fig. 1C, values for asthmatic subjects are within the dashed box).   307 
 308 
To investigate whether the enhanced release of IL-8 under hypoxia involved enhanced 309 
transcription, eosinophils were cultured under normoxia or hypoxia and the level of IL-8 310 
mRNA assessed (Fig. 1D).  Hypoxia led to stabilisation of eosinophil HIF-2α protein 311 
(Figure 1B) and up-regulation of HIF-1α-regulated transcripts BNIP3 and GLUT1 mRNA, 312 
demonstrating activation of both HIF-1α and HIF-2α -dependent signalling pathways; in 313 
contrast however, hypoxia had no effect on IL-8 mRNA levels (Fig. 1D).  Hence the 314 
increased IL-8 release evident under hypoxia may reflect enhanced release of pre-formed 315 
IL-8 as opposed to de novo biosynthesis; attempts to explore this further using 316 
transcriptional and protein synthesis inhibitors were thwarted by the extreme sensitivity of 317 
eosinophils to agents such as cyclohexamide, which induces a profound pro-apoptotic 318 
response, even at concentrations of 0.1 µg/ml. 319 
  320 
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To determine if the IL-8 released under hypoxia was biologically active, eosinophil-derived 321 
supernatants were assessed in a neutrophil chemotaxis assay using rhIL-8 as a positive 322 
control.  As shown in Fig. 1E, supernatants derived from eosinophils (from both healthy 323 
and atopic donors) cultured ex vivo under hypoxia induced neutrophil chemotaxis to the 324 
same extent as a pre-determined optimal concentration of rhIL-8, and this was inhibited by 325 
the CXCR2 antagonist SB332235Z.  A similar trend was observed for supernatants derived 326 
from eosinophils incubated under normoxia (Fig. 1E).  These data suggest that particularly 327 
within the setting of hypoxic inflammation, eosinophils may be a significant source of IL-8, 328 
capable of promoting neutrophil influx. 329 
 330 
Effects of hypoxia on eosinophil degranulation and polarisation 331 
Piecemeal degranulation is a unique eosinophil secretory mechanism, which results in a 332 
selective liberation of cytokines and chemokines and leads to a stimulus-specific 333 
eosinophil secretory profile [27][36].  In view of the effect of hypoxia on eosinophil IL-8 334 
release, we investigated additional biologically relevant secretory products and the 335 
activation status of eosinophils following hypoxic incubation. 336 
 337 
Charcot Leyden crystals are a marker of eosinophil involvement in inflammatory 338 
reactions, and persist after eosinophil death/clearance.  However, their genesis is poorly 339 
understood.  Eosinophils derived from healthy volunteers cultured under either normoxia 340 
or hypoxia failed to show any CLC formation; in contrast, eosinophils derived from 341 
atopic or asthmatic donors cultured under hypoxia for over 24 hours showed prominent 342 
CLC formation (Fig. 2A-B), which was not observed under normoxic conditions.  Co-343 
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incubation of eosinophils with dexamethasone (100 nM) did not affect basal or hypoxia-344 
induced CLC formation (Fig. 2B).  These data support the view that eosinophils from 345 
atopic donors differ from healthy donor cells and suggest that hypoxia is an important 346 
and previously unrecognised factor in CLC formation.  347 
 348 
The conversion of monomeric to filamentous actin (F-actin) is a central process 349 
underlying granulocyte motility and exocytosis.  Eosinophils cultured under hypoxia 350 
exhibited a greater degree of eotaxin-induced actin polymerisation compared to cells 351 
stimulated under normoxia (Fig. 2C and Fig. S2).  Although the fold increase in total cell 352 
F-actin content is small, localised actin polymerisation in discrete areas of the cell is 353 
essential for vesicle fusion, hence small focal increases may have profound biological 354 
relevance.  Given this, we predicted that hypoxia might impact globally on eosinophil 355 
secretion.  However, as shown in Fig. 2D the extent of IL-5-induced eosinophil-derived 356 
neurotoxin (EDN) release was actually attenuated under hypoxia; this inhibitory effect 357 
was seen in eosinophils derived from both healthy volunteers and asthmatic subjects (Fig. 358 
2D and data not shown).  Likewise, hypoxia had no effect on basal or GM-CSF-359 
stimulated CD69 expression (data not shown), which is also stored in eosinophil granules 360 
and upregulated on the eosinophil surface following cytokine stimulation or whole lung 361 
antigen challenge [37].  Together these data demonstrate that hypoxia has a nuanced 362 
effect on eosinophil secretion, specifically increasing IL-8 release and CLC formation 363 
from eosinophils derived from asthmatic/atopic but limiting the liberation of EDN. 364 
 365 
Hypoxia promotes eosinophil survival and reduces phagocytic uptake by macrophages 366 
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Although debated, impaired eosinophil apoptosis and defective phagocytic clearance 367 
(efferocytosis) has been propsed to contribute to the persistence of allergic inflammation. 368 
To determine the effects of hypoxia on eosinophil lifespan, these cells were cultured in 369 
normoxia or hypoxia in the absence or presence of IL-5, a known pro-survival stimulus.  370 
The percentage of apoptotic eosinophils measured by flow cytometry (Fig. 3A) and 371 
morphology (Fig. 3B) at 24 hours was markedly reduced by hypoxia, to a level 372 
comparable to that seen with IL-5.  Analysis of the supernatants derived from hypoxia-373 
cultured eosinophils showed no evidence of IL-5 or GM-CSF release suggesting that this 374 
was not due to an autocrine effect of these agents (data not shown).   375 
 376 
To determine whether the pro-survival effect of hypoxia on eosinophils might impair 377 
eosinophil clearance, the degree of eosinophil efferocytosis by M-CSF-differentiated 378 
MDMφ was assessed.  As shown in Fig. 3C, MDMφ uptake of eosinophils was markedly 379 
reduced when the eosinophils presented had been pre-incubated under hypoxia rather 380 
than normoxia during the previous 24 hours.  A subset of MDMφs were also placed under 381 
hypoxia for the duration of the efferocytosis assay but this had no effect on their capacity 382 
to ingest apoptotic eosinophils (Fig. 3C).  This contrasts to the ability of hypoxia or 383 
hypoxia mimetics to blunt the capacity of MDMφs to efferocytose apoptotic neutrophils 384 
(see Fig. S3).  To confirm that we were examining true efferocytosis, a subset of MDMφs 385 
were trypsinised at the end of the incubation period and examined by light microscopy, 386 
which clearly showed apoptotic cells contained within MDMφ (data not shown).  These 387 
data indicate that hypoxia impairs eosinophil apoptosis and thus clearance in vitro. 388 
 389 
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Hypoxic-mediated eosinophil survival is regulated by NF-κB and PI3-kinase 390 
To explore the role of NF-κB in conferring the pro-survival effect of hypoxia on 391 
eosinophils (as previously demonstrated in neutrophils [15]), eosinophils were incubated 392 
with the selective IKKα inhibitor GSK657311A (1-30 μM; GSK, Stevenage, UK); 393 
comparative studies were also undertaken with the PI3-kinase inhibitor LY294002 394 
(Calbiochem, Nottingham, UK), the more selective PI3-kinase Class I inhibitor 987740A 395 
(GSK, Stevenage, UK) and the JNK inhibitor SP600125 (Sigma-Aldrich, Dorset, UK).  396 
Unlike the effects seen in neutrophils, the IKKα inhibitor GSK657311A (Fig. 4A) and PI3-397 
kinase inhibitor 987740A (from GSK, Stevenage, UK)  (Fig. 4B), both caused a 398 
concentration-dependent induction of constitutive apoptosis in eosinophils even under 399 
normoxic conditions, suggesting that both signalling pathways play a tonic survival role in 400 
these cells [15][38].  Despite this, hypoxic eosinophil survival was attenuated by 401 
GSK657311A (at 30 µM), LY294002 (at 10 µM) and 987740A (at 10 µM), suggesting a 402 
role for both NF-κB and PI3-kinase signalling in this response (Fig. 4A-B).  JNK pathway 403 
inhibition with SP600125 had no effect on eosinophil apoptosis under either normoxia or 404 
hypoxia (Fig. 4B). 405 
 406 
Hypoxia attenuates dexamethasone-induced eosinophil apoptosis 407 
Having established that hypoxia has a selective effect on eosinophil secretion and induces a 408 
marked survival response, we wished to assess whether hypoxia affected the capacity of 409 
corticosteroids to induce eosinophil apoptosis.  Given that low oxygen tensions have been 410 
associated with reduced GR expression and function in other cells [39], we predicted that 411 
GR-induced eosinophil apoptosis might be impaired under hypoxia.  As shown in Fig. 5A-412 
Page | 20 Porter et al. 
 
D, precisely this effect was seen, with hypoxia causing a profound suppression of the 413 
normal concentration-dependent, pro-apoptotic effect of dexamethasone.  This was evident 414 
using either morphology or AnV/PI-binding to quantify apoptosis, was additive to the 415 
survival effect of IL-5, and was observed for up to 72 hours of culture (Fig. 5D); these data 416 
also confirmed the ability of the GR antagonist RU486 to inhibit the pro-apoptotic effect of 417 
dexamethasone (Fig. 5A).  Remarkably, the combination of IL-5 and hypoxia resulted in 418 
over 80% eosinophil survival even after 120 hours in culture compared to 100% 419 
apoptosis/necrosis of eosinophils under normoxic conditions (Fig. 5D).  Hypoxia also 420 
blocked the capacity of other high potency GCs (e.g. fluticasone fumarate) to induce 421 
eosinophil apoptosis (Fig. 5B).  Of note, the hypoxic inhibition of steroid-induced 422 
eosinophil apoptosis could be fully recapitulated by the hypoxic mimetics DFO and DMOG 423 
(Fig. 5E). 424 
 425 
Mechanism of hypoxia-mediated inhibition of dexamethasone-induced eosinophil-apoptosis 426 
From the above experiments we hypothesised that hypoxia might affect the expression or 427 
function of GR in eosinophils.  Surprisingly however, dexamethasone mediated up-428 
regulation of Gilz, a process that is fully GR-dependent [40] and was entirely preserved 429 
under hypoxia (Fig. 6A).  In these experiments Glut1 expression was used as a positive 430 
control for hypoxia whilst Iκb expression was used as a negative control.  This indicates 431 
that an intact GR-GRE axis is maintained in these cells and that hypoxia operates in a 432 
parallel but dominant manner to suppress steroid-induced eosinophil apoptosis. 433 
 434 
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Finally, to address whether the pro-apoptotic effect of corticosteroids in eosinophils is 435 
mediated via GR-transrepression or GR-transactivation, we examined the effects of a 436 
newly described GR modulator (GRT10), which has been reported to display selective 437 
GR-transrepressive effects [41].  Under normoxia, GRT10 also caused a concentration-438 
dependent increase in eosinophil apoptosis (Fig. 6B, EC50 2 nM) (and suppressed 439 
neutrophil apoptosis; see Fig. S4a), supporting the view that the pro-apoptotic capacity of 440 
GC may be mediated via a GR-transrepressive effect.  However, GRT10 was unable to 441 
promote eosinophil apoptosis under hypoxia, at any of the concentrations tested, 442 
suggesting either that hypoxia renders eosinophils insensitive to the pro-apoptotic effects 443 
of GRT10, or like dexamethasone, that the marked hypoxic pro-survival effect is 444 
sufficient to override any pro-apoptotic signalling.  445 
 446 
 447 
Discussion 448 
Inflammatory sites, including the airway wall [42][43], are often profoundly hypoxic.  449 
This results from a combination of vascular damage, the build-up of inflammatory debris, 450 
enhanced cellular metabolism, and increased oxygen extraction due to activation of 451 
NOX2 [44].  In this study we aimed to define the effects of hypoxia on eosinophil 452 
lifespan and function, and glucocorticoid sensitivity.  We confirm that hypoxia is a potent 453 
pro-survival stimulus for eosinophils as well as for neutrophils.  We also show for the 454 
first time that hypoxia reduces the ability of glucocorticoids to induce eosinophil 455 
apoptosis, inducing a state of apparent or ‘quasi’-glucocorticoid resistance.  Furthermore, 456 
hypoxic culture of eosinophils promotes the release of IL-8 to levels capable of inducing 457 
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neutrophil chemotaxis and, in cells from atopic donors, supports the formation of CLC.  458 
These data indicate that hypoxia can augment a number of potentially detrimental 459 
eosinophil functions and promote neutrophil influx. 460 
 461 
Hypoxia-induced IL-8 secretion has been reported in cancer [45], endothelial cells [46], 462 
epithelial cells and and pulmonary fibroblasts [47] as well as macrophages [48].  463 
Consensus sequences for multiple transcription factors (including AP-1, NF-κB and HIF-464 
1α) are present in the IL-8 promoter region, enabling context- and cell-dependent IL-8 465 
expression [49] [45].  In agreement with previous results [24], we show that hypoxia 466 
induces release of IL-8 from eosinophils; importantly, we also demonstrate that this is 467 
more pronounced in cells from atopic and asthmatic donors and is sufficient to promote 468 
neutrophil chemotaxis.  In vivo studies support the potential clinico-pathological 469 
relevance of these findings.  In mice, Baek et al. found that combined allergen and 470 
hypoxia challenge resulted in a 27-fold increase in the accumulation of peri-bronchial 471 
neutrophils that correlated with the release of KC (a functional homologue of IL-8) from 472 
peri-bronchial cells, including eosinophils [50].  IL-8 has been detected in airway 473 
secretions of patients with acute severe asthma, contributing to neutrophil recruitment in 474 
this setting (e.g. [51][52]); indeed, IL-8 was reported to be the only cytokine in BALF 475 
which differentiated controlled from uncontrolled asthma and correlated inversely with 476 
FEV1 [52].  Low oxygen tensions do not promote indiscriminate degranulation; indeed, 477 
EDN release was actually inhibited by hypoxia.  Selective mobilisation of pre-formed 478 
cytokines from eosinophil granule stores by ‘piecemeal degranulation’, a process which 479 
involves the trafficking of small vesicles directed by SNAP/SNARE interactions, has 480 
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been observed previously, although not in response to hypoxia; for example, eotaxin can 481 
induce the rapid and selective secretion of IL-4 from eosinophils [53], whilst IFNγ 482 
promotes IL-3 and RANTES release [54][55].  483 
 484 
We report for the first time that in vitro culture of human eosinophils results in overt CLC 485 
formation; intriguingly this was limited to cells purified from atopic donors cultured.  486 
These findings align with earlier reports of CLC formation at sites now recognised to be 487 
profoundly hypoxic, for example, within inflamed rheumatoid joints and large 488 
carcinomas [56] [57].  Given that reduced oxygen tensions have been measured at 489 
inflammatory foci and that hypoxia has been shown to regulate galectin-10 expression, it 490 
would be tempting to speculate that hypoxia in this instance predicates CLC formation, 491 
contributing to local tissue injury [9].  492 
 493 
The pro-survival effect of hypoxia on neutrophils was first described by our group some 494 
years ago [58], however the effects of hypoxia on eosinophil lifespan have been little 495 
studied.  Hypoxia has been shown to increase eosinophil viability, at least in part by the 496 
induction of the anti-apoptotic protein Bcl-XL [24].  We confirm that hypoxia is a potent 497 
pro-survival stimulus for eosinophils, and demonstrate this hypoxic survival is further 498 
augmented by cytokines.  Cells recruited to inflammatory sites in vivo will undoubtedly 499 
experience hypoxia in combination with exposure to pro-inflammatory mediators;  in in 500 
vitro experiments designed to re-capitulate this environment, we found that ≥ 80% of 501 
eosinophils cultured in the presence of both IL-5 and hypoxia were still fully viable after 502 
5 days.  Conditions such as asthma and nasal polyposis are characterised by elevated 503 
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levels of IL-5 and tissue hypoxia, particularly in severe disease [59][60].  Thus, we 504 
speculate that the combination of inflammation and hypoxia may exacerbate disease and 505 
delay resolution in this and other settings.  The physiological relevance of apoptosis to 506 
eosinophil clearance in vivo remains controversial.  While apoptotic eosinophils are 507 
readily detected in the sputum of patients with asthma, particularly in the steroid-induced 508 
resolution phase, detailed biopsy studies have offered little evidence for this event in the 509 
airway wall [61].  Whether hypoxia operates to suppress constitutive apoptosis of 510 
eosinophils within microenvironments such as inflamed airways, with re-oxygenation on 511 
exposure to oxygen in the airway lumen releasing these constraints is unknown, but 512 
would be consistent with mouse data where hypoxia increases peri-bronchial eosinophilia 513 
post OVA-challenge [50].   514 
 515 
Glucocorticoids have dichotomous effects on granulocyte lifespan, promoting neutrophil 516 
survival yet inducing eosinophil apoptosis [62].  Although corticosteroids are used to 517 
modulate inflammatory cell function within environments that may be profoundly 518 
hypoxic, few studies have examined the impact of hypoxia on the effects of these agents.  519 
Our observation that the effects of glucocorticoids on granulocyte lifespan are 520 
significantly attenuated under hypoxia initially suggested that hypoxia may render these 521 
cells steroid-insensitive.  However, qPCR analysis demonstrated that eosinophils 522 
remained intrinsically sensitive to the effects of steroids under hypoxia with 523 
dexamethasone retaining the capacity to transactivate genes such as Gilz (Fig. 6).  524 
Moreover, in preliminary experiments dexamethasone also appears to maintain its 525 
transrepressional capacity under hypoxia, causing a reduction (albeit non-significant) in 526 
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IL-8 release from eosinophils (Fig. S5).  Although in preliminary experiments GRT10 527 
still appeared capable of enhancing some expression of Gilz (regarded as a classically 528 
transactivated gene) in eosinophils (Fig. S4 B), similar effects have been seen using other 529 
apparently selective glucocorticoid receptor modulators [13], and may suggest an effect 530 
mediated by a non-classical glucocorticoid responsive element.  Thus, hypoxia appears to 531 
render granulocytes ‘quasi’ rather than truly steroid-resistant; we speculate that the reason 532 
the pro-apoptotic effects of glucocorticoids are no longer evident under hypoxia reflects 533 
the overwhelming pro-survival effect induced by hypoxia i.e. a simple competitive 534 
process between pro-apoptotic corticosteroid-driven pathways and an anti-apoptotic 535 
hypoxia-regulated mechanisms; under the experimental conditions used, that the hypoxia-536 
induced survival effect dominates, analogous to the situation previously reported in 537 
neutrophils treated with the cytokine GM-CSF [26]. 538 
 539 
The physiological and pathological environments encountered by eosinophils in vivo are 540 
either known or predicted to be hypoxic compared to arterial or venous blood.  The data 541 
presented here underscore the sensitivity of eosinophils to ambient oxygen concentration 542 
and the significant effects of hypoxia on eosinophil function.  These effects were most 543 
marked with respect to spontaneous and agonist-stimulated IL-8 and CLC generation, the 544 
survival of these cells during in vitro culture, and the attenuation of steroid-induced 545 
apoptosis.  While this paper does not assess the relevance of these findings to the in vivo 546 
situation, the ‘hypoxic’ PO2 conditions we used are well within the range of tissue 547 
oxygen values recorded, especially under disease conditions.   548 
 549 
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There has been considerable interest and debate regarding the observation that many 550 
eosinophil-targeted therapies appear to be more effective in reducing circulating 551 
eosinophil numbers compared to their capacity to reduce eosinophil numbers in tissues.   552 
One proposed mechanism in the setting of anti-IL-5 therapies is the reduction in IL-5α 553 
receptor expression in bronchoalveolar lavage eosinophils, making these cells far less IL-554 
5-dependent [63].  Our current findings may however provide an additional explaination 555 
for the enhanced eosinophil survival seen in the inflamed and hypoxic airway wall and 556 
the seeming resistance of these cells to the normal pro-apoptotic effect of corticosteroids.  557 
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Figure Legends 558 
 559 
Figure 1 560 
Hypoxia promotes stabilization of HIF-2α and the release of IL-8 from eosinophils.  561 
(a) Human eosinophils were purified from mixed leukocytes using a Robosep® negative 562 
selection strategy.  (b) Representative Western blot of HIF-2α and p38 expression 563 
immediately after isolation (0 hrs) or following 6 hrs culture of eosinophils under normoxia 564 
(N) or hypoxia (H).  Data represent mean arbitrary units (± SEM) of Western blots analysed 565 
by ImageJ from (n) = 4 independent experiments with the HIF-2α signal normalized to the 566 
p38 band.  (c) Eosinophils from healthy controls (n=8) or atopic donors (n=12) were 567 
cultured for 12 hrs under N or H and IL-8 release assessed.  (d) IL-8 mRNA levels from 568 
eosinophils cultured for 6 hrs under N or H, normalized to the housekeeping control beta-2 569 
microglobulin.  Expression of Glut1 and BNIP3 both served as positive controls for HIF-570 
regulated transcripts.  Data represent the mean ± SEM of (n) = 3 independent experiments.  571 
(e) Neutrophils were pre-incubated with or without the CXCR2 antagonist SB332235Z 572 
(100 nM) for 30 min and the degree of chemotaxis towards eosinophil supernatants 573 
(derived from healthy controls following 12 hrs N or H (n=5)) or IL-8 (100 ng/ml; n=3) 574 
assessed.  Data represent the mean ± SEM number of migrated neutrophils.  * p <0.05; ** p 575 
<0.01; *** p <0.001; **** p <0.0001; ns, not significant.  576 
 577 
Figure 2 578 
Hypoxia promotes Charcot-Leyden crystal formation but not degranulation. 579 
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(a) Representative images of CLC formation in eosinophils from an asthmatic donor 580 
cultured under hypoxia for 48 hrs; arrow indicates CLC; scale bar indicates a length of 10 581 
µM.  (b) Eosinophils cultured under normoxia or hypoxia were manually scored for the 582 
number of CLCs visible in 5 random fields of view (x40 objective) per slide.  AU 583 
Arbitary Units; 1 ≤ 25 CLCs; 2 = 25-50 CLCs; 3 = 50+ CLCs.  Data are mean from (n) = 584 
4 independent experiments, each performed in triplicate.  (c) Eosinophil actin 585 
polymerisation was assessed 4 min post-stimulation with eotaxin (100 ng/ml) following 586 
culture under normoxa (N) or hypoxia (H) for 1 hr, relative to vehicle-treated (control) or 587 
freshly isolated eosinophils; data represent the mean ± SEM of (n) = 4 independent 588 
experiments.  (d) EDN release into the supernatant was assessed by ELISA from healthy 589 
control eosinophils following 24 hrs culture with IL-5 (10 ng/ml) or vehicle under N or 590 
H.  Data represent the mean ± SEM of (n) = 3 independent experiments.   */# p <0.05; ** 591 
p <0.01; *** p <0.001; ****/#### p <0.0001 (* relative to N control; # relative to N 592 
equivalent). 593 
 594 
Figure 3 595 
Hypoxia promotes eosinophil survival, which correlates with reduced uptake by 596 
macrophages.   597 
Eosinophil apoptosis was assessed by flow cytometry (a) or morphology (b) following 24 598 
hrs culture under N or H, with or without IL-5 (10 ng/ml).  Data represent mean ± SEM 599 
from (n) = 8 independent experiments.  Representative flow plots and images are shown in 600 
the left-hand panels.  (c) Eosinophils aged under N or H for 24 hrs were co-cultured with 601 
macrophages for 1 hr under N or H and the degree of efferocytosis quantified.  602 
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Representative well images are shown in the left-hand panel.  Data represent the mean ± 603 
SD from (n) = 2 independent experiments. **** p <0.0001 relative to N control.    604 
 605 
Figure 4 606 
Hypoxia-mediated eosinophil survival is regulated by NF-κB and PI3-kinase.  607 
Eosinophil apoptosis was assessed after 24 hrs culture under normoxia or hypoxia in the 608 
presence or absence of (a) the NF-κB inhibitor GSK657311A (1 μM-30 μM), or (b) the 609 
Class 1A PI3-kinase inhibitor 987740A (1 μM-10 μM) a pan-PI3K inhibitor LY294002 610 
(LY; 10 μM) or the JNK inhibitor SP600125 (SP6; 10 μM).  Data represent the mean ± 611 
SEM of data from (n) = 4 independent experiments. ** p < 0.01, *** p < 0.001 relative to 612 
N control;  ≠ p < 0.05, ≠ ≠ p < 0.01 relative to N equivalent; # p < 0.05, ### p < 0.001 613 
relative to H control.  614 
 615 
Figure 5 616 
Concentration-dependent induction of eosinophil apoptosis by GCs is attenuated 617 
under hypoxia. 618 
(a) Eosinophil apoptosis, measured by flow cytometry, was assessed at 24 hrs following 619 
cultured under N or H in the presence or absence of dexamethasone (1 nM-1 μM), RU486 620 
(10 μM), IL-5 (10 ng/ml).  (b) Percentage of apoptotic eosinophils at 24 hrs following N or 621 
H cultures with dexamethasone (Dex: 1 μM), fluticasone furoate (FF, 100 nM), IL-5 (10 622 
ng/ml) or vehicle control.  (c) Representative flow cytometry of AnnexinV/PI stained 623 
eosinophils and cytocentrifuge images (x40) following a 24 hr culture with or without Dex 624 
under N or H.  (d) Representative time course of eosinophil apoptosis following culture 625 
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with Dex (1 μM), IL-5 (10 ng/ml) or vehicle under N or H over 120 hrs.  (e) Percentage of 626 
eosinophil apoptosis when cultured under N or H with Dex (1 μM) and hypoxia mimetics, 627 
DFO (1 mM) and DMOG (100 μM) for 24 hrs.  All data (except (d)) represent mean ± 628 
SEM of (n) = 4 independent experiments; * p < 0.05, ** p < 0.005, *** p < 0.001 relative 629 
to N control; ≠≠ p < 0.01, ≠≠≠≠ p < 0.0001 relative to the N equivalents.   630 
 631 
Figure 6 632 
GCS promote eosinophil apoptosis via a GR-transrepressive and oxygen-dependent 633 
mechanism.  634 
(a) Levels of Gilz (steroid-regulated) and GLUT1 (hypoxia-regulated) mRNA expression 635 
relative to IkB levels were examined in eosinophils cultured under N or H for 12 hour in the 636 
presence of Dex.  All transcript levels were normalised to housekeeping control beta-2 637 
microglobulin.  (b) Eosinophils were treated with increasing concentrations of the GR 638 
modulator GRT10 under N or H for 24 hrs and assessed for the degree of apoptosis by flow 639 
cytometry.  Data represent mean ± SEM of (n) = 4 independent experiments; * p < 0.05, ** 640 
p < 0.01, *** p < 0.001, relative to N control. 641 
 642 
Figure S1 643 
Hypoxia upregulates IL-8 and MIP1β release from asthmatic and healthy donors, 644 
whilst the secretion of MCP-1, RANTES, MIP1α, eotaxin and Macrophage-derived 645 
chemokine (MDC) are unaltered. 646 
Eosinophils isolated from two healthy controls and one atopic donor were cultured for 12 647 
hrs under N or H and the amount of cytokine or chemokine released into the supernatants 648 
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assessed by ELISA.  No factors were detected in supernatants derived from freshly 649 
isolated eosinophils (data not shown).  650 
 651 
Figure S2 652 
Hypoxia potentiates eotaxin-induced actin polymerization.  653 
Eosinophils were cultured for 1 hr under N or H and then treated with 100 ng/ml eotaxin 654 
or vehicle and fixed with 4% PFA, permeabilised and stained for actin with NBD-buffer 655 
and compared to freshly isolated cells.  The degree of actin polymerisation was assessed 656 
by flow cytometry with the degree of relative F-actin calculated as the ratio of the mean 657 
channel fluorescence between normoxic and hypoxic eotaxin-stimulated and non-658 
stimulated cells.  Data represent mean ± SEM from (n) = 4 independent experiments. 659 
 660 
Figure S3 661 
Phagocytosis of apoptotic neutrophils using light microscopy and quantitation of 662 
MDMφ phagocytosis of apoptotic neutrophils by flow cytometry.   663 
(a) Human M-CSF differentiated macrophages were co-incubated with apoptotic 664 
neutrophils for 1 hr under N or H before being washed and fixed with 2.5% 665 
glutaraldehyde and stained for MPO.  Representative images are shown.  (b) 666 
Phagocytosis was quantified by counting the number of macrophages (Macs) that had 667 
engulfed one or more neutrophil from duplicate wells (across five fields of view) using 668 
light microscopy.  (c) Phagocytosis was additionally assessed using flow cytometry by 669 
co-incubating macrophages with CMFDA-labelled apoptotic neutrophils for 1 hr under N 670 
or H (ingested CMFDA-labelled apoptotic neutrophils were detected as FL-1 positive).  671 
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Representative density plots of the percentage of macrophages able to phagocytose 672 
CMFDA-labelled apoptotic neutrophils under N or H are shown.  (d) To compare the 673 
effects of hypoxia mimetics, macrophages were pre-treated with DMOG (0.1–1 mM) or 674 
vehicle for 30 min before incubation under N with CMFDA-labelled apoptotic 675 
neutrophils for 1 hr before being assessed by flow cytometry.  Data represent mean ± 676 
SEM of data from (n) = 8 (b) or (n) = 3 (D) independent experiments, each conducted in 677 
duplicate.  # p < 0.05, ** p < 0.01, *** p < 0.001, relative to N control. 678 
 679 
Figure S4 680 
GCs promote neutrophil survival via a GR-transrepressive and oxygen-dependent 681 
mechanism.   682 
(a) Purified human neutrophils (PMN) or eosinophils (Eos) were treated with GR 683 
modulator GRT10 (100 μM - 100 pM) or vehicle control and cultured for 20 hours under N 684 
or H and assessed for apoptosis by flow cytometry.  (b) Purified human neutrophils and 685 
eosinophils treated with dexamethasone or GRT10 (1 nM or 1 μM) or vehicle control were 686 
cultured for 6 hours under N before RNA was harvested and expression of Gilz assessed by 687 
qPCR. Data in (a) represent mean ± SEM of data from (n) = 4 independent experiments, 688 
each conducted in duplicate; * p = <0.05.  Data in (b) represent mean ± SD of (n) = 2 689 
independent experiments, each conducted in triplicate. 690 
 691 
Figure S5 692 
Effect of hypoxia and dexamthasone on GC-mediated transrepression of IL-8 in 693 
eosinophils. 694 
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Eosinophils from healthy non-atopic (A) or atopic donors (B) were pre-incubated at 2 x 695 
106/ml at 37ºC for 8 hours in 5% CO2 in a normoxic or hypoxic environment before being 696 
pre-treated with Dex (1 μM) or vehicle for 1 hour before the further addition of TNFα (10 697 
ng/ml) or media for a further 3 hours under the same conditions.  The amount of IL-8 698 
released was assessed by ELISA and expressed in (pg/ml).  No IL-8 was detected from 699 
freshly isolated eosinophils (data not shown).  Data represent mean ± SEM of data from (n) 700 
= 3 (healthy non-atopic donors, A) or (n) = 7 (atopic donors, B) independent experiments.  701 
* P < 0.05 relative to the normoxic equivalent.  702 
 703 
  704 
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Dimethyloxaloylylglycine; EDN, Eosinophil-derived neurotoxin; Eos, Eosinophil; F-713 
actin, Filamentous actin; FF, Fluticasone furoate; fMLP, N-formyl-methionyl-leucyl-714 
phenylalanine; GC, Glucocorticosteroid; GILZ, Glucocorticoid-inducible leucine zipper; 715 
GLUT1, Glucose transporter 1; GR, Glucocorticoid receptor; H, Hypoxia (0.8% oxygen); 716 
HIF, Hypoxia inducible factor; MDMφ, Monocyte-derived macrophage; MPO, 717 
Myeloperoxidase; N, Normoxia (21% oxygen); PBS+, PI, Propidium iodide; PMN, 718 
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